Ceftobiprole

Tomasz and colleagues found that a new antibiotic called Ceftobiprole annihilated colonies of MRSA.

The Food and Drug Administration warned Johnson & Johnson that it did not properly monitor two human tests of its antibiotic drug candidate ceftobiprole, which is intended to treat complicated skin infections like MRSA.